Acoramidis demonstrates reversal of cardiac disease progression in ATTR-CM

Verifying
  • Acoramidis demonstrated reversal of cardiac structural disease progression and functional decline.
  • Acoramidis significantly increased days alive and free from hospitalization.
  • ATTR-CM was the cardiac condition associated with the reported findings.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.